Childhood BMI Linked to Increased Risk for Schizophrenia
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 16, 2024 -- Childhood body mass index (BMI) has a direct and enduring effect on the risk for schizophrenia later in life, according to a study published online Sept. 13 in Science Advances.
Pei Xiao, from Beijing Children's Hospital in China, and colleagues used data from the Psychiatric Genomics Consortium and FinnGen study to examine the causal effects of childhood and adulthood BMI on adult psychiatric disorders including Alzheimer disease, anxiety, major depressive disorder, obsessive-compulsive disorder (OCD), and schizophrenia.
The researchers found a significant association for childhood BMI with an increased risk for schizophrenia, while BMI in adulthood was associated with a reduced risk for OCD and schizophrenia. A direct causal effect of childhood BMI on schizophrenia was indicated by multivariable Mendelian randomization analyses, independent of adulthood BMI and lifestyle factors. There was no evidence of causal associations between childhood BMI and other psychiatric outcomes.
"These findings underscore the critical importance of early-life interventions to mitigate the long-term mental health consequences of childhood obesity," the authors write. "Overall, our study provides robust evidence for policymakers and health care professionals to develop targeted interventions aimed at reducing childhood obesity and mitigating its long-term consequences for mental health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
Majority of Patients With Lyme Disease Do Not Follow Up With Clinician
THURSDAY, July 10, 2025 -- Only 34 percent of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) algorithm, and of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.